Vaccine combo aims to supercharge immune attack on HPV-Positive throat cancer
Disease control
Recruiting now
This study tests whether adding two experimental HPV vaccines (pBI-11 and TA-HPV) to the standard immunotherapy drug pembrolizumab can shrink tumors or slow cancer growth in people with advanced oropharyngeal cancer that is HPV-positive. About 54 adults whose cancer has returned …
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC